This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Xencor, Inc.. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Debra Zack: Innovator in Immunology
Introduction
Debra Zack is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of immunology, particularly in the treatment of IgG4-related diseases. With a total of 2 patents to her name, her work is recognized for its innovative approaches to complex medical challenges.
Latest Patents
One of her latest patents is titled "Methods and Compositions for Inhibiting CD32B Expressing Cells in IgG4-Related Diseases." This patent focuses on immunoglobulins that bind to FcγRIIb+ B cells and coengage CD19 on the cell's surface. The methods described in this patent aim to provide new treatment options for patients suffering from IgG4-related diseases.
Career Highlights
Debra Zack is currently associated with Xencor, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in pushing the boundaries of immunological therapies, making her a key figure in her field.
Collaborations
Throughout her career, Debra has collaborated with notable professionals, including John H. Stone and Shiv Pillai. These collaborations have enriched her research and contributed to the success of her innovative projects.
Conclusion
Debra Zack's contributions to immunology through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in the treatment of complex diseases.